Πέμπτη 7 Μαΐου 2020

Coronary Stenosis Physiology and Novel Technologies.
Related ArticlesCoronary Stenosis Physiology and Novel Technologies. Rambam Maimonides Med J. 2020 Apr 29;11(2): Authors: Pravda NS, Kornowski R Abstract An accurate functional assessment of coronary artery stenosis is pivotal in the management and clinical outcomes of patients. The hemodynamic relevance of coronary artery stenoses can be assessed using coronary flow surrogates, namely fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR)....
Rambam Maimonides Med J
07:31
Type of Anemia, Chronic Non-cardiovascular Illnesses, and Outcomes of Patients with ST-segment Elevation Myocardial Infarction.
Related ArticlesType of Anemia, Chronic Non-cardiovascular Illnesses, and Outcomes of Patients with ST-segment Elevation Myocardial Infarction. Rambam Maimonides Med J. 2020 Apr 29;11(2): Authors: Menzely T, Zukermann R, Shehadeh F, Muhammad RS, Aronson D, Kapeliovich M, Kerner A, Yalonetsky S, Gepstein L, Nikolsky E Abstract OBJECTIVES: To assess the impact of different types of anemia and of concomitant non-cardiovascular chronic illnesses on outcomes...
Rambam Maimonides Med J
07:31
Modern Stents: Where Are We Going?
Related ArticlesModern Stents: Where Are We Going? Rambam Maimonides Med J. 2020 Apr 29;11(2): Authors: Kobo O, Saada M, Meisel SR, Hellou E, Frimerman A, Fanne RA, Mohsen J, Danon A, Roguin A Abstract Coronary artery stenting is the treatment of choice for patients requiring coronary angioplasty. We describe the major advancements with this technology. There have been significant developments in the design of stents and adjunctive medical therapies....
Rambam Maimonides Med J
07:31
Bioresorbable Scaffolds: Current Technology and Future Perspectives.
Related ArticlesBioresorbable Scaffolds: Current Technology and Future Perspectives. Rambam Maimonides Med J. 2020 Apr 29;11(2): Authors: Forrestal B, Case BC, Yerasi C, Musallam A, Chezar-Azerrad C, Waksman R Abstract Metallic drug-eluting stents have led to significant improvements in clinical outcomes but are inherently limited by their caging of the vessel wall. Fully bioresorbable scaffolds (BRS) have emerged in an effort to overcome these limitations,...
Rambam Maimonides Med J
07:31
CPR and ECMO: The Next Frontier.
Related ArticlesCPR and ECMO: The Next Frontier. Rambam Maimonides Med J. 2020 Apr 29;11(2): Authors: Ambinder DI, Oberdier MT, Miklin DJ, Halperin HR Abstract Cardiopulmonary resuscitation (CPR) is a first-line therapy for sudden cardiac arrest, while extracorporeal membrane oxygenation (ECMO) has traditionally been used as a means of countering circulatory failure. However, new advances dictate that CPR and ECMO could be complementary for support after...
Rambam Maimonides Med J
07:31
The Future of Stroke Interventions.
Related ArticlesThe Future of Stroke Interventions. Rambam Maimonides Med J. 2020 Apr 29;11(2): Authors: Abergel E Abstract Mechanical thrombectomy (MT) has revolutionized the treatment of large-vessel occlusion stroke and markedly improved patient outcomes. Unfortunately, there remains a large proportion of patients that do not benefit from this technology. This review takes a look at recent and upcoming technologies that may help to increase the number...
Rambam Maimonides Med J
07:31
Clinical-based Cell Therapies for Heart Disease-Current and Future State.
Related ArticlesClinical-based Cell Therapies for Heart Disease-Current and Future State. Rambam Maimonides Med J. 2020 Apr 29;11(2): Authors: Turner D, Rieger AC, Balkan W, Hare JM Abstract Patients have an ongoing unmet need for effective therapies that reverse the cellular and functional damage associated with heart damage and disease. The discovery that ~1%-2% of adult cardiomyocytes turn over per year provided the impetus for treatments that stimulate...
Rambam Maimonides Med J
07:31
New Insights into Valve Hemodynamics.
Related ArticlesNew Insights into Valve Hemodynamics. Rambam Maimonides Med J. 2020 Apr 29;11(2): Authors: Marom G, Einav S Abstract Heart valve diseases are common disorders with five million annual diagnoses being made in the United States alone. All heart valve disorders alter cardiac hemodynamic performance; therefore, treatments aim to restore normal flow. This paper reviews the state-of-the-art clinical and engineering advancements in heart valve...
Rambam Maimonides Med J
07:31

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου